For comparison, S100A12 activation was not observed in the influenza group, rarely (1 out of 49) in the other coronavirus infection group (similar to the non-hospitalized COVID-19 group), but commonly (19 out of 23) in the bacterial infection group. This evidence concerns the gene S100A12 and bacterial infectious disease.